These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10438369)

  • 1. Differential susceptibility of two species of macaques to experimental vaginal candidiasis.
    Steele C; Ratterree M; Fidel PL
    J Infect Dis; 1999 Sep; 180(3):802-10. PubMed ID: 10438369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and update on host defense against vaginal candidiasis.
    Fidel PL
    Am J Reprod Immunol; 2007 Jan; 57(1):2-12. PubMed ID: 17156186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of Candida albicans by human vaginal epithelial cells.
    Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
    J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent colonization and transient suppression of DTH responses in an estrogen-dependent vaginal candidosis murine model.
    Hamad M; Abu-Elteen KH; Ghaleb M
    New Microbiol; 2002 Jan; 25(1):65-73. PubMed ID: 11837393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal candidiasis: review and role of local mucosal immunity.
    Fidel PL
    AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct protective host defenses against oral and vaginal candidiasis.
    Fidel PL
    Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
    Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
    J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
    Witkin SS; Jeremias J; Ledger WJ
    J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL; Wormley FL; Fidel PL
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL
    Int Rev Immunol; 2002; 21(6):515-48. PubMed ID: 12650240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
    Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
    Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
    Schaller M; Korting HC; Borelli C; Hamm G; Hube B
    Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis.
    Gough PM; Warnock DW; Richardson MD; Mansell NJ; King JM
    Sabouraudia; 1984; 22(4):265-71. PubMed ID: 6390734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
    Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
    Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis.
    She XD; Wang XJ; Fu MH; Shen YN; Liu WD
    Chin Med J (Engl); 2008 Aug; 121(15):1450-5. PubMed ID: 18959125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
    Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
    J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.